Akebia Therapeutics, Inc. (AKBA)
0.9001
-0.01
(-0.72%)
USD |
NASDAQ |
Aug 24, 16:00
0.9001
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Total Assets (Quarterly) : 349.66M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 349.66M |
| March 31, 2026 | 362.52M |
| December 31, 2025 | 376.56M |
| September 30, 2025 | 364.15M |
| June 30, 2025 | 345.60M |
| March 31, 2025 | 310.18M |
| December 31, 2024 | 220.67M |
| September 30, 2024 | 207.14M |
| June 30, 2024 | 220.20M |
| March 31, 2024 | 225.48M |
| December 31, 2023 | 241.70M |
| September 30, 2023 | 235.00M |
| June 30, 2023 | 253.71M |
| March 31, 2023 | 276.86M |
| December 31, 2022 | 356.05M |
| September 30, 2022 | 435.89M |
| June 30, 2022 | 521.80M |
| March 31, 2022 | 535.36M |
| December 31, 2021 | 529.35M |
| September 30, 2021 | 602.27M |
| June 30, 2021 | 611.86M |
| March 31, 2021 | 628.70M |
| December 31, 2020 | 644.14M |
| September 30, 2020 | 676.14M |
| June 30, 2020 | 745.17M |
| Date | Value |
|---|---|
| March 31, 2020 | 787.72M |
| December 31, 2019 | 771.20M |
| September 30, 2019 | 795.22M |
| June 30, 2019 | 823.53M |
| March 31, 2019 | 890.79M |
| December 31, 2018 | 1.109B |
| September 30, 2018 | 403.83M |
| June 30, 2018 | 413.78M |
| March 31, 2018 | 442.71M |
| December 31, 2017 | 364.43M |
| September 30, 2017 | 338.59M |
| June 30, 2017 | 336.82M |
| March 31, 2017 | 259.26M |
| December 31, 2016 | 300.22M |
| September 30, 2016 | 169.12M |
| June 30, 2016 | 195.64M |
| March 31, 2016 | 221.44M |
| December 31, 2015 | 142.94M |
| September 30, 2015 | 159.59M |
| June 30, 2015 | 155.66M |
| March 31, 2015 | 103.46M |
| December 31, 2014 | 111.00M |
| September 30, 2014 | 120.17M |
| June 30, 2014 | 126.36M |
| March 31, 2014 | 134.03M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Emergent BioSolutions, Inc. | 1.117B |
| Exelixis, Inc. | 2.494B |
| ADMA Biologics, Inc. | 684.21M |
| Arcutis Biotherapeutics, Inc. | 488.54M |
| Relay Therapeutics, Inc. | 967.46M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 324.64M |
| Shareholders Equity (Quarterly) | 25.02M |
| Debt to Equity Ratio | 8.426 |
| Current Ratio | 1.427 |
| Net Debt Paydown Yield | -0.30% |